Research Opportunities

Resources for pursuing endocrine-related research opportunities

Research Policy

Endocrine researchers are at the core of solving many of the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, thyroid conditions, and hormone-related cancers. Your work has led to incredible accomplishments and remarkable progress in the biological and biomedical sciences that have benefited the lives of millions of Americans.

Highlights for Endocrine-related Research from the NIH Grants Guide

Grant Application and Peer Review Changes at NIH: Starting in January 2025, NIH will implement changes to the grant application processes and review processes for fellowship and research grants. Review the summary of upcoming changes, which will include simplifying review criteria for research project grants, revising the fellowship application and review process, and updates to related forms.

Kidney Technology Development Research Education Program: The NIH program (R25) is seeking grant applications from institutions that propose to establish research experiences in kidney technology development. Successful programs should include a collaborative capstone research or design project(s), innovative and/or ground-breaking technology development, multidisciplinary/interdisciplinary teamwork, education in entrepreneurship, product development and navigating regulatory pathways, and clinical immersion. Submit letters of intent by Thursday, June 13. 

Adaptation of Diabetes Control Technologies for Older Adults with T1D: The NIH is seeking grant applications regarding the development and testing of technologies that are adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. The deadline for letters of intent is Monday, June 17.

Women’s Health Research Funding: NIH issued a NOSI to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases, depressive disorders, Alzheimer’s disease), present and progress differently in women (e.g., cardiovascular disease, reproductive aging), or are female specific (e.g., uterine fibroids, endometriosis, menopause). Review the application deadlines.  The final expiration date is Friday, November 5, 2027.
 
PhRMA Foundation Fellowship and Grant Opportunities: The PhRMA Foundation is offering predoctoral fellowships, postdoctoral fellowships, and faculty starter grants in the areas of drug discovery, drug delivery, and translational medicine. Letters of intent are due Wednesday, May 1 at 12 PM ET.
 
Impact on Women’s Health Research Funding: The National Science Foundation (NSF) encourages the submission of research and education proposals related to women’s health in areas including but not limited to: transdisciplinary approaches to environmental challenges and opportunities to improve the understanding of climate, environment, and women's health and studies that assess theories and models of health, aging, disease, and disease transmission at multiple scales. Learn more.


NICHD to Issue ROA on Endometriosis: The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) issued a Research Opportunity Announcement (ROA) to support “Advancing Cures and Therapies and ending Endometriosis diagnostic delays.” Applications will be sought from eligible organizations to engage with NICHD to develop, advance, and/or validate new devices, biomarkers, and/or methods or repurpose existing devices for non-invasive diagnosis of endometriosis.  Learn more

Long-term Incretin Mimetic Use on Cancer Risk and Outcomes: The National Cancer Institute (NCI) issued a Notice of Special Interest (NOSI) on Epidemiologic Studies to assess the impact of incretin mimetics on new and recurrent cancer risk. The NOSI is intended to spur innovative epidemiologic on cancer risk and outcomes among individuals with and without comorbid conditions. The expiration date is Saturday, May 9, 2026. 
 
Workforce Diversity Supplements: The Office of Strategic Coordination at NIH, in collaboration with the Sexual and Gender Minority Research Office announced a NOSI supporting research supplements to promote workforce diversity and enhance utility and use of Common Fund datasets. In addition, the supplements may help promote the diversity of the scientific research workforce. The expiration date is Monday, July 1.
 
Mechanisms of Osteoarthritis Research: National Institute on Aging (NIA) and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) issued a NOSI on Mechanisms of Osteoarthritis encouraging research to explore the biological mechanisms underlying the initiation and progression of osteoarthritis.  The deadline is Saturday, May 8, 2027.


Health Disparities and Health Equity Workforce Development: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) issued a NOSI encouraging health Disparities and health equity workforce development. The NOSI intends to stimulate workforce development in biomedical research areas to eliminate health disparities and improve health equity within the scope of NIDDK’s mission diseases and conditions. The notice expires on Wednesday, April 7, 2027.

Administrative Supplements to Enhance Engagement Activity with Underserved Populations within the Type 1 Diabetes Community: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) issued a Notice of Special Interest (NOSI) as a supplement opportunity, which will support research activities that enhance outreach to and engagement with underserved populations which experience diabetes-related health disparities. The deadline is Monday, March 3, 2025.

Cancer-Related Care: Research on Telehealth and Within-Group Outcomes:  The National Cancer Institute issued two NOSIs. One notice, with an expiration date of Tuesday, March 17, 2026, highlights the interest of NCI’s Division of Cancer Control and Population Sciences in receiving investigator-initiated applications for proposing research on the use and impact of telehealth in cancer-related care, and the implications of telehealth policy changes on cancer care access, outcomes, and health equity. The second notice, which expires this year on Tuesday, April 30 announces support for administrative supplements for currently funded investigators to better understand within-group factors that contribute to cancer prevention and control outcomes and intervention effectiveness in populations that are underrepresented in or excluded from cancer research.

Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations: Several Institutes and Centers (ICs) at NIH issued a funding opportunity inviting R01 Research Project Grants addressing health and health care disparities among sexual and gender minority populations. The funding supports innovative observational and intervention-based research to identify and characterize the pathways and mechanisms through which health and health care disparities occur among sexual and gender minority populations of minoritized racial/ethnic and socio-economic statuses. View the deadlines and award cycles. The expiration date is Friday, January 8, 2027. 
 
Health Influences of Gender as a Social and Structural Variable: The NIH issued a NOSI highlighting interest in receiving research and training grant applications focused on the health impacts of gender-related social and structural variables. Issues relevant to this notice include gender roles and norms, gender relations, gender equity/inequity, gender equality/inequality, gender-related power dynamics, and structural sexism. The note expires on Wednesday, October 1, 2025.

Supplements for Health-Related Research Careers: Administrative supplements will be available to provide full or part-time mentored research training experiences for individuals with high potential to re-enter, re-integrate into, or re-train in an active research career after an interruption for family responsibilities or other qualifying circumstances. The grants are intended to provide scientists with an opportunity to update or extend their research skills and prepare them to re-establish their careers in basic biomedical, behavioral, clinical, translational, or social science research. Submit your application by October 9, 2026.

Funding Opportunity: Improving Care and Outcomes for Cancer Survivors in SGM Populations: The NCI intends to support the assessment of barriers to quality cancer treatment and follow-up care for sexual and gender minority (SGM) cancer survivors. Funding is intended to address a critical need for improved care delivery and outcomes for SGM cancer survivors, an underserved and understudied population that is at higher risk of poorer health outcomes. Letters of intent are due 30 days prior to the application date, which closes on Monday, October 5, 2026
 
Impact of Family on Sexual and Gender Minority (SGM) Individuals: The National Institutes of Health issued a notice supported by several institutes and centers with an interest in research on the impact of familial support and rejection on the health and well-being of SGM individuals across the life course. Research proposals may include behavioral, social, clinical, and any other relevant research approaches probing the influence of familial response and actions towards SGM individuals. The expiration date is Wednesday, May 8, 2026.  


Integrity and Bias Awareness Training will be Required for NIH Reviewers:
The NIH Center for Scientific Review (CSR) has developed two reviewer training modules (already successfully implemented by CSR for several review cycles) that will now be required by all reviewers prior to participating in NIH review meetings, effective for the May 2024 Council round. The first is on “bias awareness and mitigation”, and the second is on “review integrity”. Each training takes approximately 30 minutes and must be completed every three years. 

Extramural Loan Repayment Program for Researchers: The Extramural Loan Repayment Program (LRP) repays up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research at a domestic, nonprofit, or government entity. External LRPs exist for clinical researchers, pediatric researchers, health disparities researchers, researchers in emerging areas critical to human health, individuals from disadvantaged backgrounds, contraception and infertility researchers, and researchers addressing the heterogeneity of obesity risk, related health outcomes, and response to treatment. Application due dates vary by topic.

Research Supplements to Promote Diversity in Health-Related Research: The NIH and CDC are funding administrative supplements for projects that enhance the diversity of the research workforce by recruiting, mentoring, and supporting high school, undergraduate and graduate/clinical students, postbaccalaureate and post Masters individuals, postdoctoral researchers (including health professionals), and eligible investigators from diverse backgrounds. Submission dates vary by the awarding Institute/Center.

NIH Prohibits the Use of AI in Peer Review: The NIH issued a notice informing the extramural research community that the use of natural language processors, large language models, or other generative Artificial Intelligence (AI) technologies for analyzing and formulating peer review critiques for grant applications is prohibited. Uploading or sharing content or original concepts from an NIH grant application, contract proposal, or critique to AI tools violates the NIH peer review confidentiality and integrity requirements.

COVID-19 Impacted NIMH Research Supplements: The purpose of this Notice of Special Interest (NOSI) is to outline priorities for providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that experienced significant setbacks as result of the COVID-19 pandemic, which were unable to be resolved with non-monetary options (e.g., modification to the project or re-budgeting to accomplish aims). Applications will be accepted on a rolling basis through Wednesday, April 2, 2026. Submit your application.

Small Research Grants for Innovations in Healthy Longevity Research: The National Institute on Aging (NIA) released a Notice of Special Interest (NOSI) to support research on aging, the aging process, and diseases and conditions associated with growing older. Submit your application by Wednesday, May 8

NIDDK Releases Report: Health Disparities and Equities: NIDDK announced the release of “Pathways to Health for All,” a new report from its Health Disparities and Health Equity Research Working Group of Council, which makes innovative recommendations to advance research in health equity and health disparities. It also includes guiding principles for embedding equity into research activities and tips for researchers who plan to engage in robust health equity research.

Secondary Analyses of Existing Datasets in Aging Research: The National Institute on Aging encourages the use of existing cohorts and datasets for secondary analyses to investigate novel scientific ideas and/or address clinically related issues on: (1) aging changes influencing health across the lifespan (2) diseases and disabilities in older persons, and/or (3) the changes in basic biology of aging that underlie these impacts on health. First application has passed but receipt dates are still open through Wednesday, May 8, 2024

Aging Research Dissertation Awards to Promote Diversity: The National Institute on Aging invites R36 applications to support senior graduate students with Aging Research Dissertation Awards to Promote Diversity. These awards provide funding to support graduate students from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, in finishing their dissertations on aging and aging-related health conditions. Submit your application for receipt dates through Wednesday, October 16

Funding Opportunity on Clinical Trial Readiness for Rare Diseases: This funding opportunity invites researchers to submit applications for support of projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics toward clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials. View the awards cycles and applicate due dates that extend through Thursday, October 17, 2024.  

Funding Research with Activities Related to Diversity (ReWARD): The NIH’s ReWARD Program provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who have no current NIH research project grant funding. The expiration date is Thursday, May 7, 2026 for this program that provides funding for both the scientific research and the DEIA activities of investigators. 

NIDDK Issuing Small R01s for Clinical Trials: There is a funding opportunity for the submission of pilot and feasibility clinical trials in humans that will lay the foundation for larger clinical trials related to the prevention and/or treatment of diseases and conditions within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). For more information, please review the full notice.

Chronic Conditions Understudied Among Women: The purpose of this funding opportunity is to invite R01 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and/or underreported in biomedical research. The final application deadline is Thursday, February 5, 2026.  

Exploratory Health Disparities Research Grant: The National Institute on Minority Health and Health Disparities (NIMHD) announced a grant to fund new exploratory or developmental research projects that have the potential to break new ground in the fields of minority health and health disparities. View the deadlines and awards cycle.  The final expiration date is Friday, May 8, 2026.

Addressing the Impact of Structural Racism and Discrimination in Minority Health and Health Disparities: The NIH announced a new R01 that will support intervention research to address the impact of structural racism and discrimination (SRD) on minority health and health disparities. Research designs should allow for the assessment of mechanisms through which the intervention modifies SRD and how these changes result in improvement in the targeted health outcomes. Application deadlines and the award cycles are now available. View the application deadlines and the award cycles. The final expiration date is Thursday, January 8, 2026.   

Time-Sensitive Research Opportunities in Environmental Health Sciences: The NIH released a funding opportunity announcement (FOA) that is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to collect human biological samples or environmental exposure data. A feature of an appropriate study is the need for rapid review and funding; the entire cycle, from submission to award, is expected to be within 4-6 months. The final cycle deadline is Monday, December 1, 2025.

Climate Change and Healthcare Research: The Agency for Healthcare Research and Quality (AHRQ) are interested in receiving health services research grant applications that address the intersection of climate change and healthcare. Specifically, applications that address three primary areas: 1) Reducing the healthcare sector’s greenhouse gas emissions and carbon footprint, 2) Creating resilient healthcare systems and communities that can plan, prepare, respond, and adapt to climate-related threats, and 3) Addressing the inequitable impacts of climate change. Learn more

Mood and Psychosis Research During the Menopause Transition: The NIH issued a funding opportunity announcement (FOA) to encourage applications that will advance mechanistic and translational research on the onset and worsening of mood and psychotic disorders during the menopausal transition. In particular, they are seeking proposals that will advance the understanding of the underlying neurobiological and behavioral mechanisms during the menopause transition that will identify novel targets for future mental health interventions. Learn more

NIH Grants Policy Changes: The NIH announced that they have published updated “Significant Changes” made to the NIH Grants Policy Statement (GPS) in fiscal year 2022 that will be reflected in the GPS for 2023. Highlights include an updated definition of terms (added the data management and sharing plan, unique entity identifier, etc.), a new section titled “NIH Disclosure Requirements,” and a new section titled “Plans to Promote Safe Environments at Conferences”, among others. about the changes.

Continuity of Research Among First-Time NIH Grant Recipients Administrative Supplement: This retention program seeks to maintain the productivity of current first-time recipients of eligible independent NIH research project grant awards who are dealing with a critical life event(s), such that they can remain competitive for the first renewal of their award or for a second research project grant award. The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. The final application deadline is due on Wednesday, October 1, 2025.

Trailblazer Award Opportunity for New and Early Stage Investigators: The Trailblazer Award is an opportunity for new and early stage investigators to pursue research programs that integrate engineering and the physical sciences with the life and/or biomedical sciences. A Trailblazer project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Applicants must propose research approaches for which there are minimal or no preliminary data. View the application due dates and award cycles. The final application deadline is Thursday, October 16, 2025

Maximizing Investigators’ Research Award for Early Stage Investigators: The National Institute of General Medical Sciences (NIGMS) announced they are planning to issue a funding opportunity announcement (FOA) to continue the Maximizing Investigators’ Research Award for Early Stage Investigators (MIRA-ESI) R35 program. ESIs are encouraged to submit an application that falls within the mission of NIGMS before the final application cycle deadline of Tuesday, February 3, 2026.

Urgent Competitive Revisions to Existing NIH Grants: The NIH announced that Principal Investigators on specific types of NIH research grants may apply to funds for competitive revisions to meet immediate needs to help address a specific public health crisis which were unforeseen when the application was submitted. Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the Notice of Award of the most recent parent award. The expiration date is Sunday, October 26, 2025. Review the full notice. 

Women’s Health Research in Institutional Development Award (IDeA)-eligible States: The NIH announced a Notice of Special Interest (NOSI) to support women’s health research in Institutional Development Award (IDeA)-eligible states. The proposed research must address at least one of the strategic goals of the Trans-NIH Strategic Plan for Women's Health Research “Advancing Science for the Health of Women” to enable innovative research relevant to the health of women and to address emerging women’s health issues of public importance. The final application deadline is Friday, January 31, 2025.

Resources and Technologies for Enhancing Rigor and Reproducibility: The Office of Research Infrastructure Programs (ORIP) encourages research project grant applications aimed at developing and implementing broadly applicable technologies, tools, and resources for validating animal models and enhancing rigor, reproducibility, and translatability of animal research. The earliest submission date is Wednesday, June 5, 2025. Review the award cycles. 

Intersection of Sex and Gender Influences on Health and Disease: The NIH issued a funding opportunity announcement (FOA) to invite R01 applications on the influence and intersection of sex and gender in health and disease. This FOA supports basic, preclinical, translational, and clinical research investigations. The final application deadline is Friday, November 22, 2024. Review the award cycles.

Development of Animal Models and Related Materials Funding: The Office of Research Infrastructure Programs (ORIP) issued a Funding Opportunity Announcement (FOA) encouraging grant applications aimed at developing, characterizing or improving animal models of human diseases. The animal models, related materials, or technological tools developed must be broadly applicable to the scientific interests of two or more NIH Institutes or Centers and must evaluate diseases and processes that impact multiple organ systems. Applications will be accepted on a rolling basis through Monday, May 26, 2025. For more information, please review the application due dates and award cycles.

The National Cancer Institute (NCI)issued a notice of intent to publish a funding opportunity announcement inviting R01 and R21 applications for research projects that identify and define the mechanisms that link diet with lipid metabolism-mediated tumor growth and progression. For more information, please see the full notice for the R01 and R21.

The National Cancer Institute (NCI) Funding Opportunity for Cancer Research: NCI issued a funding opportunity announcement (FOA) to support studies for a Phase II or later phase trial. The NCI intends to support clinical trials aimed at improving cancer prevention/interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. View the awards cycles and applicate due dates that extend through Wednesday, June 25, 2025. Learn more.

NIA Announces K22 Awards: The National Institute of Aging (NIA) announced the NIA Career Transition Award (CTA) to facilitate the transition of mentored researchers to tenure-track faculty positions conducting research that advances the mission of NIA. This award will provide three years of protected time through salary and research support to conduct biomedical research at an extramural sponsoring institution/organization to which the individual has been recruited, been offered, and has accepted a tenure-track full-time assistant professor position (or equivalent). Expiration date is Sunday, October 13. Learn more.

NIH Issues MOSAIC FOAs: The Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) program is part of NIH’s efforts to enhance diversity within the academic biomedical research workforce, and is designed to facilitate the transition of promising postdoctoral researchers from diverse backgrounds, for example individuals from groups underrepresented in the biomedical research workforce at the faculty level, into independent, tenure-track or equivalent research-intensive faculty positions. Expiration date is Sunday, October 6. Please see the relevant guide notices (clinical trial not allowed, independent clinical trial required, and independent basic experimental studies with humans required) for more information.

NOSI for Placental Research: The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) issued a Notice of Special Interest (NOSI) encouraging research on several “High Priority Areas in Placental Research for Healthy Pregnancies”. Topics of special emphasis in these areas include, but are not limited, to 1) Elucidating the gene-regulatory pathways and molecular mechanisms involved in trophoblast differentiation and function; 2) Understanding the role of the immune system in normal placentation and pregnancy rejection; and 3) Developing safe and effective therapeutics for the treatment of placental dysfunction/disorders. Research addressing themes of diversity and inclusion are also highly encouraged. The notice expires October 6, 2024.

NOSI for Secondary Analysis of Human Connectome Data: Several NIH institutes issued a Notice of Special Interest (NOSI) to encourage secondary analyses of data from the Human Connectome Project (HCP) including the multiple datasets in the Lifespan Human Connectome projects and the Human Connectomes Related to Human Disease. Applicants beyond the groups that originally collected the data are encouraged to apply. For more information, see the announcement in the grants guide or the website for the Connectome Coordination Facility. The expiration date is Thursday, May 8.

New Early Investigator Grant: National Institutes of Health recently announced the Stephen I. Katz Early Stage Investigator Research Project Grant award. This new award will support early stage investigators (ESIs) for innovative projects in an area of science that represents a change in research direction for the investigator. Importantly, applications will not be allowed to submit preliminary data. The final due dates are Monday, September 28, 2026 and Monday December 28, 2026 for AIDS and AIDS-related applications. Apply today! For other information, see the NIH Notice.


Additional Resources

Data Repositories

The following resources may be useful for researchers seeking data repositories, databases, or other opportunities for data deposition and/or sharing.

Research Supporters

United States

Global

Publishing Your Research

Tips on Getting Published in Endocrine Society Journals

Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.

Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.

Publishing Your Research

Benefits of Publishing in Endocrinology

Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, shares why you should submit your research to our journal. The Society now waives page and color charges for Society members. The journal has also seen a surge of citations.

Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, shares why you should submit your research to our journal. The Society now waives page and color charges for Society members. The journal has also seen a surge of citations.

Take Action

Make Your Voice Heard

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.